对糖尿病视网膜病变的抵抗力
Anara Serikbaeva1, Yanliang Li2, Simon Ma3
1Department of Physiology and Biophysics, University of Illinois at Chicago, 1905 W Taylor St, Chicago, IL 60612, USA.
Progress in retinal and eye research
|May 13, 2024
概括
糖尿病视网膜病变 (DR) 耐药性与早期糖尿病 (DM) 期间视网膜中的线粒体防御有关. 了解这些保护机制可能会导致延迟DR发作的疗法.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 线粒体生物学 线粒体生物学
背景情况:
- 糖尿病中慢性高血糖导致糖尿病视网膜病变 (DR),这是视力丧失的主要原因.
- 高血糖症的早期阶段会引起微妙的视网膜变化,而长时间暴露会导致明显的,可检测的损伤.
- 在高血糖的初始阶段,防止最大视网膜损伤的机制尚不清楚.
研究的目的:
- 探索在高血糖早期对糖尿病视网膜病变 (DR) 产生抵抗力的保护机制.
- 研究基于线粒体的防御系统在维持视网膜健康的作用,尽管糖尿病 (DM).
主要方法:
- 这项研究回顾了糖尿病视网膜病变背景下关于线粒体功能和防御通路的最近发现.
- 在早期高血糖症期间,对视网膜中细胞弹性机制的分析.
主要成果:
- 糖尿病 (DM) 激活了基于线粒体的防御机制,提供了对视网膜病变的暂时抵抗阶段.
- 这种线粒体弹性的恶化会导致逐渐的视网膜损伤.
结论:
- 线粒体防御在糖尿病 (DM) 过渡性视网膜病变耐药阶段起着至关重要的作用.
- 识别这种保护的生物标志物和媒介是开发糖尿病视网膜病变 (DR) 新型,基于弹性疗法的关键.
- 针对这些保护性通路的治疗策略可以无限期地延迟DR的发病和进展.
相关概念视频
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59


